Mario Guralnik
Career history of Mario Guralnik
Former positions of Mario Guralnik
| Companies | Position | Start | End |
|---|---|---|---|
Ora Bio Ltd.
 Ora Bio Ltd. Pharmaceuticals: MajorHealth Technology Ora Bio Ltd. engaged in the repositioning of existing drugs for second-use applications. The firm develops its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration. The company was founded by Yossi Israeli and Amichai Baron in June 2005 and is headquartered in Nazareth Illit, Isreal. | Corporate Officer/Principal | 2010-03-03 | - |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Mario Guralnik
| University of California, Los Angeles | Doctorate Degree |
Statistics
International
| United States | 3 |
| Israel | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ora Bio Ltd.
Ora Bio Ltd. Pharmaceuticals: MajorHealth Technology Ora Bio Ltd. engaged in the repositioning of existing drugs for second-use applications. The firm develops its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration. The company was founded by Yossi Israeli and Amichai Baron in June 2005 and is headquartered in Nazareth Illit, Isreal. | Health Technology |
- Stock Market
- Insiders
- Mario Guralnik
- Experience
